A detailed history of Compton Wealth Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Compton Wealth Advisory Group, LLC holds 11,627 shares of ABBV stock, worth $2.04 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
11,627
Previous 11,710 0.71%
Holding current value
$2.04 Million
Previous $2.01 Million 14.34%
% of portfolio
0.59%
Previous 0.54%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$163.84 - $199.33 $13,598 - $16,544
-83 Reduced 0.71%
11,627 $2.3 Million
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $69,965 - $81,703
452 Added 4.01%
11,710 $2.01 Million
Q1 2024

Apr 11, 2024

BUY
$159.82 - $182.1 $16,301 - $18,574
102 Added 0.91%
11,258 $2.05 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $158,928 - $178,990
1,155 Added 11.55%
11,156 $1.73 Million
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $8,683 - $10,052
65 Added 0.65%
10,001 $1.49 Million
Q2 2023

Jul 26, 2023

SELL
$132.51 - $164.9 $23,719 - $29,517
-179 Reduced 1.77%
9,936 $1.34 Million
Q1 2023

Apr 26, 2023

BUY
$144.61 - $166.54 $865,057 - $996,242
5,982 Added 144.74%
10,115 $1.61 Million
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $13,831 - $16,587
100 Added 2.48%
4,133 $668,000
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $11,273 - $12,930
-84 Reduced 2.04%
4,033 $541,000
Q2 2022

Jul 29, 2022

BUY
$137.62 - $174.96 $35,781 - $45,489
260 Added 6.74%
4,117 $630,000
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $165,634 - $205,506
1,255 Added 48.23%
3,857 $625,000
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $18,477 - $23,379
-172 Reduced 6.2%
2,602 $352,000
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $1,915 - $2,174
18 Added 0.65%
2,774 $299,000
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $1,893 - $2,109
18 Added 0.66%
2,756 $310,000
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $2,762 - $3,040
27 Added 1.0%
2,738 $296,000
Q4 2020

May 17, 2021

BUY
$80.49 - $108.67 $218,208 - $294,604
2,711 New
2,711 $290,000
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $246,943 - $333,399
-3,068 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$85.91 - $100.83 $35,137 - $41,239
409 Added 15.38%
3,068 $269,000
Q2 2020

Aug 10, 2020

BUY
$73.37 - $98.18 $1,980 - $2,650
27 Added 1.03%
2,659 $261,000
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $12,900 - $19,558
200 Added 8.22%
2,632 $200,000
Q4 2019

Feb 03, 2020

SELL
$72.13 - $90.25 $774,676 - $969,285
-10,740 Reduced 81.54%
2,432 $215,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $49,502 - $59,515
-786 Reduced 5.63%
13,172 $997,000
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $1.09 Million - $1.34 Million
13,958 New
13,958 $1.29 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Compton Wealth Advisory Group, LLC Portfolio

Follow Compton Wealth Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compton Wealth Advisory Group, LLC with notifications on news.